Cellectis (CLLS) Minority Interest (2014 - 2023)
Cellectis (CLLS) recorded quarterly Minority Interest of $5.4 million in Q2 2023, up 120.12% quarter-over-quarter from $2.4 million in Q1 2023, and up 60.89% on a YoY basis from $3.4 million in Q2 2022.
Cellectis (CLLS) Minority Interest (2014 - 2023) Analysis & Trends
Cellectis' Minority Interest history runs 10 years deep, the most recent figure standing at $5.4 million for Q2 2023.
- In Q2 2023, Minority Interest rose 60.89% year-over-year to $5.4 million; the TTM figure through Jun 2023 stood at $5.4 million (up 60.89% YoY), while the FY2022 annual figure was $7.9 million, down 48.0% from the prior year.
- Minority Interest was $5.4 million for Q2 2023 at Cellectis, up from $2.4 million in the prior quarter.
- In the past five years, Minority Interest ranged from a high of $41.3 million in Q2 2019 to a low of $2.4 million in Q1 2023.
- Historically, Minority Interest has averaged $22.1 million across 5 years, with a median of $24.6 million in 2020.
- The sharpest annual moves came in 2019 and 2022: Minority Interest surged 2472.25% in 2019, then plunged 89.77% in 2022.
- A 5-year view of Minority Interest shows it stood at $13.1 million in 2019, then soared by 90.92% to $25.1 million in 2020, then tumbled by 39.4% to $15.2 million in 2021, then plunged by 47.48% to $8.0 million in 2022, then plunged by 32.36% to $5.4 million in 2023.
- The last three Minority Interest figures came in at $5.4 million (Q2 2023), $2.4 million (Q1 2023), and $8.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 5.39 Mn |
| Mar 31, 2023 | 2.45 Mn |
| Dec 31, 2022 | 7.97 Mn |
| Sep 30, 2022 | 8.97 Mn |
| Jun 30, 2022 | 3.35 Mn |
| Mar 31, 2022 | 2.85 Mn |
| Dec 31, 2021 | 15.18 Mn |
| Sep 30, 2021 | 24.18 Mn |
| Jun 30, 2021 | 26.46 Mn |
| Mar 31, 2021 | 27.82 Mn |
| Dec 31, 2020 | 25.05 Mn |
| Sep 30, 2020 | 35.84 Mn |
| Jun 30, 2020 | 37.45 Mn |
| Mar 31, 2020 | 38.74 Mn |
| Dec 31, 2019 | 13.12 Mn |
| Sep 30, 2019 | 41.14 Mn |
| Jun 30, 2019 | 41.28 Mn |
| Mar 31, 2019 | 41.16 Mn |
| Dec 31, 2018 | 40.97 Mn |
| Sep 30, 2018 | 40.67 Mn |